Glycyrrhizin represses total parenteral Nutrition-Associated acute liver injury in rats by Suppressing Endoplasmic Reticulum Stress

International Journal of Molecular Sciences

Volumn 14, Issue 6, 2013, Pages 12563-12580

  Tsai, Jai Jen ^a   Kuo, Hsing Chun ^b   Lee, Kam Fai ^c   Tsai, Tung Hu ^a,d,e  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

^b CHANG GUNG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Taiwan)

^c CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^d CHINA MEDICAL UNIVERSITY   (Taiwan)

^e TAIPEI CITY HOSPITAL   (Taiwan)

Author keywords

Endoplasmic reticulum (ER); Glycyrrhizin; Total parenteral nutrition (TPN)

Indexed keywords

3 NITROTYROSINE; ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; GLYCYRRHIZIC ACID; GROWTH ARREST AND DNA DAMAGE INDUCIBLE PROTEIN 153; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 1BETA; INTERLEUKIN 6; MITOGEN ACTIVATED PROTEIN KINASE P38; REACTIVE NITROGEN SPECIES; SODIUM CHLORIDE; STRESS ACTIVATED PROTEIN KINASE 1; SUPPRESSOR OF CYTOKINE SIGNALING 3; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA; 3-NITROTYROSINE; AUTACOID; CASPASE 3; CYTOKINE; SOCS3 PROTEIN, RAT; STRESS ACTIVATED PROTEIN KINASE; SUPPRESSOR OF CYTOKINE SIGNALING; TYROSINE;

ACUTE LIVER INJURY; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BILIRUBIN BLOOD LEVEL; CONTROLLED STUDY; CYTOKINE PRODUCTION; DOSE RESPONSE; DRUG EFFECT; ENDOPLASMIC RETICULUM STRESS; ENZYME PHOSPHORYLATION; IN VIVO STUDY; LIVER INJURY; LIVER PROTECTION; MALE; NONHUMAN; PROTEIN EXPRESSION; RAT; TOTAL PARENTERAL NUTRITION; TRIACYLGLYCEROL BLOOD LEVEL; UPREGULATION; ADVERSE EFFECTS; ANALOGS AND DERIVATIVES; ANIMAL; APOPTOSIS; BLOOD; CHEMISTRY; COMPLICATION; DRUG EFFECTS; ENZYMOLOGY; IMMUNOHISTOCHEMISTRY; INFLAMMATION; INJURIES; LIVER; LIVER DISEASES; METABOLISM; PATHOLOGY; PHOSPHORYLATION; SPRAGUE DAWLEY RAT;

GLYCYRRHIZA; RATTUS;

ANIMALS; APOPTOSIS; BILIRUBIN; CASPASE 3; CYTOKINES; ENDOPLASMIC RETICULUM STRESS; GLYCYRRHIZIC ACID; IMMUNOHISTOCHEMISTRY; INFLAMMATION; INFLAMMATION MEDIATORS; JNK MITOGEN-ACTIVATED PROTEIN KINASES; LIVER; LIVER DISEASES; MALE; NITRIC OXIDE SYNTHASE TYPE II; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PARENTERAL NUTRITION, TOTAL; PHOSPHORYLATION; RATS, SPRAGUE-DAWLEY; REACTIVE NITROGEN SPECIES; SUPPRESSOR OF CYTOKINE SIGNALING PROTEINS; TRANSCRIPTION FACTOR CHOP; TRIGLYCERIDES; TYROSINE;

EID: 84879187858     PISSN: 16616596     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms140612563     Document Type: Article

References (54)

1. Chance, W.T.; Sheriff, S.; Dayal, R.; Friend, L.A.; Thomas, I.; Balasubramaniam, A. The role of polyamines in glucagon-like peptide-2 prevention of TPN-induced gut hypoplasia. Peptides 2006, 27, 883-892.
2. Stoll, B.; Horst, D.A.; Cui, L.; Chang, X.; Ellis, K.J.; Hadsell, D.L.; Suryawan, A.; Kurundkar, A.; Maheshwari, A.; Davis, T.A.; et al. Chronic parenteral nutrition induces hepatic inflammation, steatosis, and insulin resistance in neonatal pigs. J. Nutr. 2010, 140, 2193-2200.
3. Raman, M.; Allard, J.P. Parenteral nutrition related hepato-biliary disease in adults. Appl. Physiol. Nutr. Metable 2007, 32, 646-654.
4. Sandhu, I.S.; Jarvis, C.; Everson, G.T. Total parenteral nutrition and cholestasis. Clin. Liver Dis. 1999, 3, 489-508.
5. Kumpf, V.J. Parenteral nutrition-associated liver disease in adult and pediatric patients. Nutr. Clin. Pract. 2006, 21, 279-290.
6. Cavicchi, M.; Beau, P.; Crenn, P.; Degott, C.; Messing, B. Prevalence of liver disease and contributing factors in patients receiving home parenteral nutrition for permanent intestinal failure. Ann. Intern. Med. 2000, 132, 525-532.
7. Luman, W.; Shaffer, J.L. Prevalence, outcome and associated factors of deranged liver function tests in patients on home parenteral nutrition. Clin. Nutr. 2002, 21, 337-343.
8. Attili, A.F.; Angelico, M.; Cantafora, A.; Alvaro, D.; Capocaccia, L. Bile acid-induced liver toxicity: Relation to the hydrophobic-hydrophilic balance of bile acids. Med. Hypotheses. 1986, 19, 57-69.
9. Tomar, B.S. Hepatobiliary abnormalities and parenteral nutrition. Indian J. Pediatr. 2000, 67, 695-701.
10. Brinkman, A.S.; Murali, S.G.; Hitt, S.; Solverson, P.M.; Holst, J.J.; Ney, D.M. Enteral nutrients potentiate glucagon-like peptide-2 action and reduce dependence on parenteral nutrition in a rat model of human intestinal failure. Am. J. Physiol. Gastrointest Liver Physiol. 2012, 303, 610-622.
11. Jain, A.K.; Stoll, B.; Burrin, D.G.; Holst, J.J.; Moore, D.D. Enteral bile acid treatment improves parenteral nutrition-related liver disease and intestinal mucosal atrophy in neonatal pigs. Am. J. Physiol. Gastrointest Liver Physiol. 2012, 302, 218-224.
12. Loff, S.; Kranzlin, B.; Moghadam, M.; Dzakovic, A.; Wessel, L.; Back, W.; Hosie, S.; Wirth, H.; Waag, K.L. Parenteral nutrition-induced hepatobiliary dysfunction in infants and prepubertal rabbits. Pediatr. Surg. Int. 1999, 15, 479-482.
13. Shamir, R.; Zahavi, I.; Bar-Sever, Z.; Heckelman, B.; Marcus, H.; Dinari, G. Total parenteral nutrition-associated cholestasis after selective damage to acinar zone 3 hepatocytes by bromobenzene in the rat. Life Sci. 1993, 52, 371-376.
14. Zahavi, I.; Rosezki, O.; Stolkart, Y.; Shamir, R.; Heckelman, B.; Marcus, H.; Dinari, G. The effect of cisapride on total parenteral nutrition-associated cholestasis in rats. Isr. Med. Assoc. J. 2000, 2, 91-93.
15. Hong, L.; Wang, X.; Wu, J.; Cai, W. Mitochondria-initiated apoptosis triggered by oxidative injury play a role in total parenteral nutrition-associated liver dysfunction in infant rabbit model. J. Pediatr. Sur. 2009, 4, 1712-1718.
16. Laborie, S.; Lavoie, J.C.; Chessex, P. Paradoxical role of ascorbic acid and riboflavin in solutions of total parenteral nutrition: Implication in photoinduced peroxide generation. Pediatr. Res. 1998, 43, 601-606.
17. Knowles, H.; Li, Y.; Perraud, A.L. The TRPM2 ion channel, an oxidative stress and metabolic sensor regulating innate immunity and inflammation. Immunol. Res. 2013, 55, 241-248.
18. Egwuagu, C.E.; Yu, C.R.; Zhang, M.; Mahdi, R.M.; Kim, S.J.; Gery, I. Suppressors of cytokine signaling proteins are differentially expressed in Th1 and Th2 cells: Implications for Th cell lineage commitment and maintenance. J. Immunol. 2002, 168, 3181-3187.
19. Yu, C.R.; Mahdi, R.M.; Ebong, S.; Vistica, B.P.; Chen, J.; Guo, Y.; Gery, I.; Egwuagu, C.E. Cell proliferation and STAT6 pathways are negatively regulated in T cells by STAT1 and suppressors of cytokine signaling. J. Immunol. 2004, 173, 737-746.
20. Yoshimura, A.; Suzuki, M.; Sakaguchi, R.; Hanada, T.; Yasukawa, H. SOCS, Inflammation, and autoimmunity. Front. Immunol. 2012, 3, 20.
21. Tazuke, Y.; Drongowski, R.A.; Btaiche, I.; Coran, A.G.; Teitelbaum, D.H. Effects of lipid administration on liver apoptotic signals in a mouse model of total parenteral nutrition (TPN). Pediatr. Surg. Int. 2004, 20, 224-228.
22. Ferri, K.F.; Kroemer, G. Organelle-specific initiation of cell death pathways. Nat. Cell. Biol. 2001, 3, 255-263.
23. Wang, H.C.; Huang, W.; Lai, M.D.; Su, I.J. Hepatitis B virus pre-S mutants, endoplasmic reticulum stress and hepatocarcinogenesis. Cancer Sci. 2006, 97, 683-688.
24. Katz, M.S.; Thatch, K.A.; Schwartz, M.Z. Dose variation of hepatocyte growth factor and its effects on an animal model of TPN-induced liver injury. J. Surg. Res. 2010, 163, 294-298.
25. Liu, J.; Ren, F.; Cheng, Q.; Bai, L.; Shen, X.; Gao, F.; Busuttil, R.W.; Kupiec-Weglinski, J.W.; Zhai, Y. Endoplasmic reticulum stress modulates liver inflammatory immune response in the pathogenesis of liver ischemia and reperfusion injury. Transplantation 2012, 94, 211-217.
26. Ashfaq, U.A.; Masoud, M.S.; Nawaz, Z.; Riazuddin, S. Glycyrrhizin as antiviral agent against Hepatitis C Virus. J. Transl. Med. 2011, 9, 112.
27. Liao, H.L.; Ma, T.C.; Li, Y.C.; Chen, J.T.; Chang, Y.S. Concurrent use of corticosteroids with licorice-containing TCM preparations in Taiwan: A National Health Insurance Database study. J. Altern. Complement. Med. 2010, 16, 539-544.
28. Asl, M.N.; Hosseinzadeh, H. Review of pharmacological effects of Glycyrrhiza sp. and its bioactive compounds. Phytother. Res. 2008, 22, 709-724.
29. Del Prete, A.; Scalera, A.; Iadevaia, M.D.; Miranda, A.; Zulli, C.; Gaeta, L.; Tuccillo, C.; Federico, A.; Loguercio, C. Herbal products: Benefits, limits, and applications in chronic liver disease. Evid. Based Complement. Alternat. Med. 2012, 2012, 837939.
30. Stickel, F.; Schuppan, D. Herbal medicine in the treatment of liver diseases. Dig. Liver Dis. 2007, 39, 293-304.
31. Makuuchi, M.; Kokudo, N.; Arii, S.; Futagawa, S.; Kaneko, S.; Kawasaki, S.; Matsuyama, Y.; Okazaki, M.; Okita, K.; Omata, M.; et al. Development of evidence-based clinical guidelines for the diagnosis and treatment of hepatocellular carcinoma in Japan. Hepatol. Res. 2008, 38, 37-51.
32. Van der kallen, C.J.; van greevenbroek, M.M.; Stehouwer, C.D.; Schalkwijk, C.G. Endoplasmic reticulum stress-induced apoptosis in the development of diabetes: Is there a role for adipose tissue and liver? Apoptosis 2009, 14, 1424-1434.
33. Farley, N.; Pedraza-Alva, G.; Serrano-Gomez, D.; Nagaleekar, V.; Aronshtam, A.; Krahl, T.; Thornton, T.; Rincón, M. p38 mitogen-activated protein kinase mediates the Fas-induced mitochondrial death pathway in CD8+ T cells. Mol. Cell. Biol. 2006, 26, 2118-2129.
34. McGuinness, O.P.; Donmoyer, C.; Ejiofor, J.; McElligott, S.; Lacy, D.B. Hepatic and muscle glucose metabolism during total parenteral nutrition: Impact of infection. Am. J. Physiol. 1998, 275, E763-E769.
35. Jiménez, W.; Clária, J.; Arroyo, V.; Rodés, J. Carbon tetrachloride induced cirrhosis in rats: A useful tool for investigating the pathogenesis of ascites in chronic liver disease. J. Gastroenterol. Hepatol. 1992, 7, 90-97.
36. Manns, M.P.; Wedemeyer, H.; Singer, A.; Khomutjanskaja, N.; Dienes, H.P.; Roskams, T.; Goldin, R.; Hehnke, U.; Inoue, H.; European SNMC Study Group. Glycyrrhizin in patients who failed previous interferon alpha-based therapies: Biochemical and histological effects after 52 weeks. J. Viral Hepat. 2012, 19, 537-546.
37. Yoshikawa, M.; Matsui, Y.; Kawamoto, H.; Umemoto, N.; Oku, K.; Koizumi, M.; Yamao, J.; Kuriyama, S.; Nakano, H.; Hozumi, N.; et al. Effects of glycyrrhizin on immune-mediated cytotoxicity. J. Gastroenterol. Hepatol. 1997, 12, 243-248.
38. Kao, T.C.; Shyu, M.H.; Yen, G.C. Glycyrrhizic acid and 18beta-glycyrrhetinic acid inhibit inflammation via PI3K/Akt/GSK3beta signaling and glucocorticoid receptor activation. J. Agric. Food Chem. 2010, 58, 8623-8629.
39. Wei, X.Q.; Charles, I.G.; Smith, A.; Ure, J.; Feng, G.J.; Huang, F.P.; Xu, D.; Muller, W.; Moncada, S.; Liew, F.Y. Altered immune responses in mice lacking inducible nitric oxide synthase. Nature 1995, 375, 408-411.
40. Nussler, A.K.; Billiar, T.R. Inflammation, immunoregulation, and inducible nitric oxide synthase. J. Leukoc. Biol. 1993, 54, 171-178.
41. Minc-Golomb, D.; Tsarfaty, I.; Schwartz, J.P. Expression of inducible nitric oxide synthase by neurones following exposure to endotoxin and cytokine. Br. J. Pharmacol. 1994, 112, 720-722.
42. Ialenti, A.; Ianaro, A.; Moncada, S.; di Rosa, M. Modulation of acute inflammation by endogenous nitric oxide. Eur J. Pharmacol. 1992, 211, 177-182.
43. Fan, C.K.; Lin, Y.H.; Hung, C.C.; Chang, S.F.; Su, K.E. Enhanced inducible nitric oxide synthase expression and nitrotyrosine accumulation in experimental granulomatous hepatitis caused by Toxocaracanis in mice. Parasite Immunol. 2004, 26, 273-281.
44. Gorbunov, N.V.; McFaul, S.J.; Januszkiewicz, A.; Atkins, J.L. Pro-inflammatory alterations and status of blood plasma iron in a model of blast-induced lung trauma. Int. J. Immunopathol. Pharmacol. 2005, 18, 547-556.
45. Di Giannantonio, M.; Frydas, S.; Kempuraj, D.; Karagouni, E.; Hatzistilianou, M.; Conti, C.M.; Boucher, W.; Papadopoulou, N.; Donelan, J.; Cao, J.; et al. Cytokines in stress. Int. J. Immunopathol. Pharmacol. 2005, 18, 1-5.
46. Feng, Y.; Ralls, M.W.; Xiao, W.; Miyasaka, E.; Herman, R.S.; Teitelbaum, D.H. Loss of enteral nutrition in a mouse model results in intestinal epithelial barrier dysfunction. Ann. N. Y. Acad. Sci. 2012, 1258, 71-77.
47. Feng, Y.; McDunn, J.E.; Teitelbaum, D.H. Decreased phospho-Akt signaling in a mouse model of total parenteral nutrition: A potential mechanism for the development of intestinal mucosal atrophy. Am. J. Physiol. Gastrointest Liver Physiol. 2010, 298, 833-841.
48. Koeberlein, B.; zur Hausen, A.; Bektas, N.; Zentgraf, H.; Chin, R.; Nguyen, L.T.; Kandolf, R.; Torresi, J.; Bock, C.T. Hepatitis B virus overexpresses suppressor of cytokine signaling-3 (SOCS3) thereby contributing to severity of inflammation in the liver. Virus Res. 2010, 148, 51-59.
49. Sasaki, A.; Yasukawa, H.; Shouda, T.; Kitamura, T.; Dikic, I.; Yoshimura, A. CIS3/SOCS-3 suppresses erythropoietin (EPO) signaling by binding the EPO receptor and JAK2. J. Biol. Chem. 2000, 275, 29338-29347.
50. Boden, G.; Song, W.; Duan, X.; Cheung, P.; Kresge, K.; Barrero, C.; Merali, S. Infusion of glucose and lipids at physiological rates causes acute endoplasmic reticulum stress in rat liver. Obesity 2011, 19, 1366-1373.
51. Kamiya, T.; Nishihara, H.; Hara, H.; Adachi, T. Ethanol extract of Brazilian red propolis induces apoptosis in human breast cancer MCF-7 cells through endoplasmic reticulum stress. J. Agric. Food Chem. 2012, 60, 11065-11070.
52. Malhi, H.; Kaufman, R.J. Endoplasmic reticulum stress in liver disease. J. Hepatol. 2011, 54, 795-809.
53. Riedl, S.J.; Shi, Y. Molecular mechanisms of caspase regulation during apoptosis. Nat. Rev. Mol. Cell. Biol. 2004, 5, 897-907.
54. Yeh, Y.T.; Hur, S.S.; Chang, J.; Wang, K.C.; Chiu, J.J.; Li, Y.S.; Chien, S. Matrix stiffness regulates endothelial cell proliferation through Septin 9. PLoS One 2012, 7, e46889.